Navigation Links
Viagra Offers Hope In Treatment Of Crohn’s Diseas

A recent study has shown that Crohn’s disease could due to ineffective functioning of a weak immune system. It was previously thought that an overactive immune system could be responsible // for this chronic inflammatory disorder characterized by ulcers in the small and large intestines. The following finding has been revealed by research conducted by researchers from University College London (UCL).

The researchers compared the immune response of Crohn’s sufferers and controls (healthy individuals) to minor injuries (skin abrasions). The experimental group members were found to produce low levels of neutrophils (white blood cells that fight infection) and other chemicals involved in combating inflammation.

In order to confirm the findings, the researchers further determined their ability to fight against a harmless form of bacteria, taken from under the skin. The control group members were found to have an enhanced blood flow to the inflamed area while those with Crohn’s disease had an insignificant increase in blood flow.

Surprisingly, Viagra, given for the treatment of erectile dysfunction / impotence has been found to result in increased blood flow among Crohn's sufferers. Following such a promising finding, we might soon have an alternative drug to treat this inflammatory bowel disorder.

It is hypothesized that Crohn’s disease sufferers have weakened immune systems, incapable of destroying bacteria invading the intestinal wall. This allows bacterial growth and colonization, eventually paving way for secretion of inflammatory substances that trigger Crohn's symptoms.

The improvement in symptoms following treatment aimed at stimulation of white blood cells and the gene mutation associated with Crohn’s disease further support the fact that the disease is a manifestation of a weak immune system.

With our improved understanding of the disease process, it might be possible to treatment the disease more effec tively in the future.

'"/>




Related medicine news :

1. Viagra for heart and lung patients
2. Viagra Also Found To Be Effective For Treatment of Lung Diseases
3. The Use Of Viagra for Babies Questioned
4. Viagra Used More By Young Men
5. Treating Altitude Sickness With Viagra
6. Treating Pulmonary Arterial Hypertension In Children With Viagra
7. Women complain Viagra users want too much sex
8. FDA Diminish Hopes On ‘Female Viagra
9. Impotence drug such as Viagra may cause Vision Loss
10. Viagra Halves Effect Of Hormonal Stress On Heart
11. Viagra Drug for improving blood circulation
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/18/2017)... ... 17, 2017 , ... Butler Mobility invited Ken Matthews to visit its manufacturing ... Ken was impressed with the safety and reliability of the Stannah Stairlift as ... show. This endorsement by Ken Matthews can be heard on News Radio WHP ...
(Date:2/17/2017)... ... February 17, 2017 , ... Smiles by Seese is ... in Davidson, NC. Dr. Brian Seese leads the practice as a skilled and highly ... one roof. Smiles by Seese serves patients of all ages with excellence in general, ...
(Date:2/17/2017)... VA (PRWEB) , ... February ... ... FDA Device Approval and Reimbursement , **An FDAnews Webinar**, Feb. 22, 2017 ... What are the critical reimbursement questions manufacturers should be asking before selecting ...
(Date:2/17/2017)... ... February 17, 2017 , ... Program ... , Trinity Health and the U.S. Soccer Foundation announced today that they have ... communities. Soccer for Success, the Foundation’s soccer mentoring program, teaches kids the fundamentals ...
(Date:2/17/2017)... GA (PRWEB) , ... February 17, 2017 , ... Like ... to reduce readmissions. Driven in large part by the Hospital Readmission Reduction Program (HRRP), ... been a key focus area for hospitals across the nation. While many providers are ...
Breaking Medicine News(10 mins):
(Date:2/18/2017)... 2017 Research and Markets has announced the addition ... their offering. ... provides separate comprehensive analytics for the US, Canada , ... Asia-Pacific , Latin America , and Rest of ... 2022. Also, a six-year historic analysis is provided for these markets. Market ...
(Date:2/17/2017)... Conn. , Feb. 17, 2017 Arvinas ... of drugs based on protein degradation, today announced the ... receptor (AR) PROTAC during a poster session at the ... (ASCO GU) in Orlando, FL. ... to validate our platform and the potential of PROTACs ...
(Date:2/17/2017)... 2017   Risperdal lawsuits involving gynecomastia (male breast ... use of the atypical antipsychotic medication continue to move ... of Common Pleas, where the state,s Risperdal docket has ... a notice posted on the Court,s website , ... March 9, 2017 at 11:00 a.m. (In Re: Risperdal ...
Breaking Medicine Technology: